Literature DB >> 19851890

Activation of p38 MAPK pathway by hepatitis C virus E2 in cells transiently expressing DC-SIGN.

Qiu-Li Chen1, Shi-Ying Zhu, Zhong-Qi Bian, Lan-Juan Zhao, Jie Cao, Wei Pan, Zhong-Tian Qi.   

Abstract

Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN) is a cellular receptor for hepatitis C virus for the binding of viral envelope glycoprotein E2. Interaction of DC-SIGN with the E2 may evoke cellular signal transduction implicated in viral pathogenesis. We developed a cell model with DC-SIGN transient transfection to study p38 mitogen-activated protein kinase (MAPK) signaling pathway in response to the E2 treatment. HEK293T and HeLa were DC-SIGN-deficient cell lines. DC-SIGN was detectable at the surface of HEK293T and HeLa transfected with DC-SIGN, and the levels of DC-SIGN were high in transfected-HEK293T as compared with HeLa. The transfected-HEK293T displayed ability for the E2 binding. In the transfected-HEK293T, level of p38 MAPK phosphorylation was increased upon the E2 treatment and reduced following blockage of DC-SIGN with an antibody against DC-SIGN. Phosphorylation of downstream transcription factor activating transcription factor (ATF)-2 was also up-regulated by the E2 via DC-SIGN. Similar results were obtained with NIH3T3 cells stably expressing DC-SIGN and Huh7 cells. Our results indicate that DC-SIGN transient expression in HEK293T is a useful cell model for investigating p38 MAPK pathway triggered by the E2, which may provide information for understanding cellular receptors-mediated signaling events and the viral pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19851890     DOI: 10.1007/s12013-009-9069-0

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  7 in total

1.  Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2.

Authors:  Teresa R Johnson; Jason S McLellan; Barney S Graham
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

2.  Hepatitis C Virus Protein Interaction Network Analysis Based on Hepatocellular Carcinoma.

Authors:  Yuewen Han; Jun Niu; Dong Wang; Yuanyuan Li
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

3.  Inhibition of miR-148a-3p resists hepatocellular carcinoma progress of hepatitis C virus infection through suppressing c-Jun and MAPK pathway.

Authors:  Yibin Deng; Jianchu Wang; Meijin Huang; Guidan Xu; Wujun Wei; Houji Qin
Journal:  J Cell Mol Med       Date:  2018-12-18       Impact factor: 5.310

Review 4.  C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity.

Authors:  Urban Svajger; Marko Anderluh; Matjaz Jeras; Natasa Obermajer
Journal:  Cell Signal       Date:  2010-04-02       Impact factor: 4.315

5.  Pharmacological perturbation of CXCL1 signaling alleviates neuropathogenesis in a model of HEVA71 infection.

Authors:  Saravanan Gunaseelan; Mohammed Zacky Ariffin; Sanjay Khanna; Mong How Ooi; David Perera; Justin Jang Hann Chu; John Jia En Chua
Journal:  Nat Commun       Date:  2022-02-16       Impact factor: 17.694

6.  ERK signaling is triggered by hepatitis C virus E2 protein through DC-SIGN.

Authors:  Lan-Juan Zhao; Wen Wang; Hao Ren; Zhong-Tian Qi
Journal:  Cell Stress Chaperones       Date:  2013-02-03       Impact factor: 3.667

7.  Differential gene expressions of the MAPK signaling pathway in enterovirus 71-infected rhabdomyosarcoma cells.

Authors:  Weifeng Shi; Xueling Hou; Xiang Li; Hongjun Peng; Mei Shi; Qingbo Jiang; Xiping Liu; Yun Ji; Yuhua Yao; Caizhen He; Xiangdong Lei
Journal:  Braz J Infect Dis       Date:  2013-06-21       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.